Effect of alteration of caveolin-1 expression on doxorubicin-induced apoptosis in H9c2 cardiac cells.

作者: Akira Takaguri , Maiko Kamato , Yoshiaki Satoh , Kazuaki Ohtsuki , Kumi Satoh

DOI: 10.1002/CBIN.10478

关键词:

摘要: Doxorubicin is an anthracycline antibiotic widely used in cancer treatment. Although its antitumor efficacy appears to be dose dependent, clinical use greatly restricted by the development of cardiotoxicity associated with apoptosis. caveolin-1, major structural protein caveolae, can positively or negatively regulate apoptosis depending on stimulus cell types, contribution caveolin-1 doxorubicin-induced remains unknown. This study was performed identify regulatory role H9c2 cardiac cells using a genetic approach. Caveolin-1 knockdown short hairpin (sh) RNA adenovirus, but not overexpression wild-type resulted marked inhibition caspase-3 cleavage. However, tended protect against decrease viability, it did significantly reverse death induced doxorubicin. stimulated phosphorylation p38 and extracellular signal regulated kinase (ERK). Doxorubicin-induced cleavage inhibited U0126, MEK inhibitor SB203580, inhibitor. markedly p-38 ERK-mediated p-53 cells. Our results suggest that reduced expression plays anti-apoptotic insufficient prevent such

参考文章(36)
Cécile Boscher, Ivan Robert Nabi, CAVEOLIN-1: Role in Cell Signaling Advances in Experimental Medicine and Biology. ,vol. 729, pp. 29- 50 ,(2012) , 10.1007/978-1-4614-1222-9_3
Weilin Hu, Yumei Ge, David M. Ojcius, Dexter Sun, Haiyan Dong, X. Frank Yang, Jie Yan, p53 signalling controls cell cycle arrest and caspase-independent apoptosis in macrophages infected with pathogenic Leptospira species Cellular Microbiology. ,vol. 15, pp. 1642- 1659 ,(2013) , 10.1111/CMI.12141
Lilach Tencer, Mordechai Liscovitch, Elke Burgermeister, Matthias P Ebert, Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance. Anticancer Research. ,vol. 28, pp. 895- 906 ,(2008)
James M. Olson, Andrew R. Hallahan, p38 MAP kinase: a convergence point in cancer therapy Trends in Molecular Medicine. ,vol. 10, pp. 125- 129 ,(2004) , 10.1016/J.MOLMED.2004.01.007
Glaucia E Callera, Augusto CI Montezano, Alvaro Yogi, Rita CA Tostes, Rhian M Touyz, Vascular signaling through cholesterol-rich domains: implications in hypertension. Current Opinion in Nephrology and Hypertension. ,vol. 16, pp. 90- 104 ,(2007) , 10.1097/MNH.0B013E328040BFBD
Qing-Bai She, Nanyue Chen, Zigang Dong, ERKs and p38 Kinase Phosphorylate p53 Protein at Serine 15 in Response to UV Radiation Journal of Biological Chemistry. ,vol. 275, pp. 20444- 20449 ,(2000) , 10.1074/JBC.M001020200
Ana R. Lehenbauer Ludke, Abd Al-Rahman S. Al-Shudiefat, Sanjiv Dhingra, Davinder S. Jassal, Pawan K. Singal, A concise description of cardioprotective strategies in doxorubicin-induced cardiotoxicity. Canadian Journal of Physiology and Pharmacology. ,vol. 87, pp. 756- 763 ,(2009) , 10.1139/Y09-059
Lauren Brown, Samuel Benchimol, The Involvement of MAPK Signaling Pathways in Determining the Cellular Response to p53 Activation CELL CYCLE ARREST OR APOPTOSIS Journal of Biological Chemistry. ,vol. 281, pp. 3832- 3840 ,(2006) , 10.1074/JBC.M507951200
Wei-Tien Chang, Jing Li, Hsien-Hao Haung, Huiping Liu, Mei Han, Srinivasan Ramachandran, Chang-Qing Li, Willard W. Sharp, Kimm J. Hamann, Chun-Su Yuan, Terry L. Vanden Hoek, Zuo-Hui Shao, Baicalein protects against doxorubicin‐induced cardiotoxicity by attenuation of mitochondrial oxidant injury and JNK activation Journal of Cellular Biochemistry. ,vol. 112, pp. 2873- 2881 ,(2011) , 10.1002/JCB.23201